Reaction
Application Site Haemorrhage reporting signals
As of the last recalculation, Application Site Haemorrhage appears in 2,725 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is PEGFILGRASTIM (PRR 220.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Pegfilgrastim | 1,397 | 220.8 | 224.0 |
| Glycerin, Lidocaine | 88 | 49.6 | 49.9 |
| Docosanol | 89 | 47.9 | 48.2 |
| Minoxidil Foam 5% (Womens) | 53 | 12.5 | 12.5 |
| Minoxidil | 63 | 10.9 | 11.0 |
| Miconazole Nitrate | 9 | 7.9 | 7.9 |
| Buprenorphine | 87 | 7.4 | 7.4 |
| Estradiol | 78 | 7.1 | 7.1 |
| Dalteparin Sodium | 9 | 6.5 | 6.5 |
| Nicotine | 29 | 5.5 | 5.5 |
| Methylphenidate | 20 | 5.3 | 5.3 |
| Mupirocin Calcium | 9 | 5.0 | 5.0 |
| Crisaborole | 6 | 4.8 | 4.8 |
| Oxybutynin | 14 | 3.7 | 3.7 |
| Rotigotine | 6 | 3.2 | 3.2 |
| Evolocumab | 45 | 2.1 | 2.1 |
| Guselkumab | 9 | 1.9 | 1.9 |